Taping Intelligence Interrogations, and Various Resources
A new Department of Defense policy memorandum requires the videotaping of intelligence interrogations of prisoners in DoD custody, including interrogations that are performed by the Central Intelligence Agency. “As a condition of having access to conduct strategic intelligence interrogations, individuals representing other U.S. Government agencies, interagency mobile interrogation teams, and foreign governments must comply with this [policy] when conducting strategic intelligence interrogations,” the DoD memorandum states. See “Videotaping or Otherwise Electronically Recording Strategic Intelligence Interrogations of Persons in the Custody of the Department of Defense” (pdf), Directive-Type Memorandum (DTM) 09-031, May 10, 2010.
Background on recent upheaval in the Central Asian country of Kyrgyzstan is presented in “The April 2010 Coup in Kyrgyzstan: Context and Implications for U.S. Interests” (pdf), Congressional Research Service, May 7, 2010.
The nuclear research reactors that were constructed at Oak Ridge National Laboratory during its 66-year history, only one of which is still operational, were described and illustrated in “An Account of Oak Ridge National Laboratory’s Thirteen Nuclear Reactors” by Murray W. Rosenthal, August 2009 (revised March 2010).
Intelligence community policy on preparing independent cost estimates in support of the National Intelligence Program budget was set forth in “Independent Cost Estimates” (pdf), Intelligence Community Directive (ICD) 109, April 26, 2010.
The U.S. Army’s vision of the future development of unmanned aircraft systems for situational awareness and combat operations was presented in “U.S. Army Roadmap for UAS 2010-2035” (pdf), April 2010.
Commercial artificial intelligence tools have recently emerged that are able to produce police reports. If the resulting reports are inaccurate, incomplete or biased, or if the process leaks confidential information, this could undermine the criminal justice system and harm citizens.
Too often, affected patients, clinicians, and regulators cannot see how the system works, why a decision was made, or whether meaningful human oversight occurred.
Existing tools from other domains, such as existing robust public engagement processes in drug development, when applied to AI deployment can help strengthen public trust in these systems and enhance perceptions of their legitimacy and the decisions they produce.
With thoughtful policy action, it is still possible to build systems that are fair, transparent, and accountable, and to earn the public trust that will ultimately determine AI’s future. We hope policymakers are ready to act.